Secondary Hypogonadism: Clinical Trials

9 trials for Secondary Hypogonadism, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed. 9 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 39Completed 9

Follow Secondary Hypogonadism: new trials by email Literature Review of Secondary Hypogonadism trials Research Report on Secondary Hypogonadism

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Randomized, Double Blind, Placebo-Controlled, Multi-Center Phase III Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Testosterone and Sperm Concentration Following Treatment With 12.5 mg or 25 mg Androxal or AndroGel 1.62%
Androxal 12.5 mg/25 mg, Placebo Capsules, AndroGel 1.62% - Secondary Hypogonadism
Phase 3CompletedRepros Therapeutics Inc.1202014-01-012014-10-01
A Randomized, Double Blind, Placebo-Controlled, Multi-Center Phase III Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Testosterone and Sperm Concentration Following Treatment With 12.5 mg or 25 mg Androxal or AndroGel 1.62%
Androxal 12.5 mg or 25 mg, AndroGel 1.62%, Placebo Capsules - Secondary Hypogonadism
Phase 3CompletedRepros Therapeutics Inc.1202014-01-012014-10-01
Phase III Study to Evaluate Morning Testosterone Normalization in Overweight Men With Secondary Hypogonadism
enclomiphene citrate, Placebo - Secondary Hypogonadism
Phase 3CompletedRepros Therapeutics Inc.1812012-11-012015-05-27
An Extension Study of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism
Androxal - Secondary Hypogonadism
Phase 3CompletedRepros Therapeutics Inc.3002012-11-012014-04-16
Phase III Study to Evaluated Morning Testosterone Normalization in Men With Secondary Hypogonadism
Androxal, Placebo - Secondary Hypogonadism
Phase 3CompletedRepros Therapeutics Inc.1512012-08-012015-05-27
Safety Study of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism
Androxal - Secondary Hypogonadism
Phase 3CompletedRepros Therapeutics Inc.4992012-05-012014-07-24
Study to Evaluate the Safety and Efficacy of Androxalâ„¢ Treatment in Men With Secondary Hypogonadism
Androxal, AndroGel, Placebo - Secondary Hypogonadism
Phase 3CompletedRepros Therapeutics Inc.1942006-03-012010-02-11
Study to Evaluate the Safety and Efficacy of Androxal Treatment in Men With Secondary Hypogonadism
Androxal - Secondary Hypogonadism
Phase 3CompletedRepros Therapeutics Inc.1042006-03-012014-06-27
Long-term Safety Study of Intramuscular Injections of 750 mg and 1000 mg Testosterone Undecanoate in Hypogonadal Men
Testosterone Undecanoate 750 mg, Testosterone Undecanoate 1000 mg - Hypogonadism, Primary Hypogonadism
Phase 3CompletedEndo USA Inc., a Keenova Therapeutics Company5312006-03-012017-10-05

Narrower conditions

Hypogonadism (9)

Broader conditions

Endocrine System Diseases (9)  ·  Gonadal Disorders (9)

Interventions

Enclomiphene (8)  ·  Testosterone (1)  ·  testosterone undecanoate (1)

Sponsors

Repros Therapeutics Inc. (8)  ·  Endo USA Inc., a Keenova Therapeutics Company (1)

Countries

United States (8)

Top investigators

Joseph S Podolski (3)  ·  Andre van As, MD, PhD (2)